[
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"Mutation",
        "aa_mutation":"Mutation",
        "disease":"Hepatocellular Carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"KRAS",
        "genomic_position":"12:25362365-25403737(-)",
        "cds_mutation":"c.35G>A",
        "aa_mutation":"p.G12D",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":4,
        "response_to_drug":"Sensitivity",
        "therapies":"Refametinib + Sorafenib",
        "description":null,
        "rs_value":121913529.0,
        "pmid":"PubMed:NCT01915602"
    },
    {
        "gene_name":"EGFR",
        "genomic_position":"7:55086794-55279321(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"ERBB2",
        "genomic_position":"17:37856333-37884915(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Varlitinib",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT03499626"
    },
    {
        "gene_name":"TP53",
        "genomic_position":"17:7571720-7590856(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"rAD-p53",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02418988"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"unspecified_and_KLB_unspecified",
        "aa_mutation":"unspecified_and_KLB_unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V510M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"FGFR4",
        "genomic_position":"5:176513887-176525145(+)",
        "cds_mutation":"c.?",
        "aa_mutation":"p.V550M",
        "disease":"hepatocellular_carcinoma",
        "therapy_rank":1,
        "response_to_drug":"Resistance",
        "therapies":"Fisogatinib",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:31575540"
    },
    {
        "gene_name":"NOTCH1",
        "genomic_position":"9:139388896-139440314(-)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"Ginsenoside Rg3 capsule + Pirarubicin",
        "description":null,
        "rs_value":null,
        "pmid":"ClinicalTrials.gov:NCT02724358"
    },
    {
        "gene_name":"JAK2",
        "genomic_position":"9:4985245-5128183(+)",
        "cds_mutation":"unspecified",
        "aa_mutation":"unspecified",
        "disease":"liver | carcinoma | hepatocellular carcinoma",
        "therapy_rank":3,
        "response_to_drug":"Sensitivity",
        "therapies":"AZD1480",
        "description":null,
        "rs_value":null,
        "pmid":"PubMed:NCT01219543"
    }
]